Simranjit Bedi, DO
Gastroenterology · Longmont, CONPI 1447678271
Payments from drug & device makers
Across 575 payments — averaging $21.72 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$3K
- Takeda Pharmaceuticals U.S.A., Inc.$1K
- Johnson & Johnson$1K
- Sanofi$968
- Gilead$701
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$630
- plus $4K from 26 others
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 169 | $3,354 |
| Takeda Pharmaceuticals U.S.A., Inc. | 69 | $1,429 |
| Johnson & Johnson | 60 | $1,329 |
| Sanofi | 28 | $968 |
| Gilead | 30 | $701 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 35 | $630 |
| Regeneron Healthcare Solutions, Inc. | 20 | $544 |
| QOL Medical, LLC | 26 | $497 |
| Phathom Pharmaceuticals, Inc. | 16 | $376 |
| Bristol Myers Squibb | 23 | $370 |
| Aimmune Therapeutics, Inc. | 20 | $365 |
| Celltrion USA Inc. | 11 | $351 |
| Ardelyx, Inc. | 9 | $263 |
| Nestle Healthcare Nutrition Inc. | 12 | $207 |
| Lilly USA, LLC | 7 | $129 |
| Covidien LP | 1 | $125 |
| Madrigal Pharmaceuticals | 4 | $113 |
| Pfizer | 5 | $98 |
| Intercept Pharmaceuticals, Inc. | 5 | $96 |
| Braintree Laboratories, Inc. | 4 | $91 |
| Ferring Pharmaceuticals Inc. | 5 | $80 |
| Medtronic | 1 | $75 |
| Boehringer Ingelheim | 2 | $61 |
| Organon | 2 | $47 |
| Merck | 2 | $45 |
| Redhill Biopharma Inc. | 2 | $34 |
| Olympus America Inc. | 2 | $27 |
| Ipsen Biopharmaceuticals, Inc | 1 | $20 |
| Daiichi Sankyo Inc. | 1 | $19 |
| Shield Therapeutics Inc | 1 | $18 |
| Apollo Endosurgery US Inc | 1 | $16 |
| Boston Scientific | 1 | $14 |
How this compares
$12,489 in reported general payments places this provider in the 80th percentile of 304 gastroenterology providers in Colorado.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other gastroenterology in Longmont
- David GatofLongmont$24K
- Scot LeweyLongmont$15K
- Tamas OtrokLongmont$11K
- Bhaktasharan PatelColorado Springs$22M
- Marcelo KugelmasEnglewood$2.7M
- Douglas AdlerColorado Springs$1.2M
- Masi KhajaGrand Junction$1.2M
- Peter McNallyFt Carson$1.1M
- Mark GerichAurora$1M
- Raj ShahAurora$764K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.